Skip to main content

Epigenetics Market Growth Rate, Share, Demand by Regions, Types and Analysis of Key Players

What are the Global Growth Factors?

The key factors that are driving the growth of Epigenetics Market include the decreasing sequencing costs and time, increase in research activities to identify and develop inhibitors/drugs for various diseases, funding for epigenetics research, and rising prevalence of cancer.

What The Experts Says about the Market Growth?

The epigenetics market is projected to reach $1,605.7 million by 2022 from an estimated $854.0 million in 2017, at a CAGR of 13.5% during the forecast period. 

Growing applications in Personalized Medicine and Targeted Therapy in Oncology is a growth opportunity for the Epigenetics market

According to a press release published by the Tufts Center for the Study of Drug Development in May 2015, biopharmaceutical companies have nearly doubled their R&D investments in personalized medicine over the last five years, and these investments are further expected to increase by 33% over the next five years. This will further drive the use of epigenetics tools.

Among the Application Segments, Oncology Dominated the Global Epigenetics Market in 2016

Based on application, the oncology segment accounted for the largest share of the Epigenetics Market in 2016. The large share of this segment can be attributed to the rising prevalence of cancer and the increasing number of research-related activities.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=896

Geographical Analysis:

North America accounted for the largest share of the Epigenetics Market in 2016, followed by Europe. Increase in epigenetics research activities, favorable government funding initiatives, high R&D expenditure, rising incidence of various diseases, and the presence of key players in the region are the key factors driving the growth of the Epigenetics Market in North America.

Key Market Players:

The major players in the Global Epigenetics Market are Illumina (US), Thermo Fisher (US), Diagenode (Belgium), QIAGEN (US), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US), Agilent (US), Zymo Research (US), PerkinElmer (US), and Bio-Rad (US).

Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) - Global Forecast to 2022
Labels:

Comments

Post a Comment

Popular posts from this blog

Dental Bone Graft Substitutes Market worth $664.3 Million by 2021

According to a new market research report  " Dental Bone Graft Substitutes Market by Type (Synthetic Bone Grafts, Xenografts, Allografts, and Demineralized Allografts), by Application (Sinus Lift, Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, and Implant Bone Regeneration), by Product (Biooss, Osteograf, Grafton, and Others) - Forecast to 2021" , published by MarketsandMarkets, The global market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as technological advancements in the field of dental bone grafts and increase in the number of bone grafting procedures are expected to drive the growth of the global dental bone grafts substitutes market. Several insurance providers in the U.S. and various countries in the European region have assisted the medical sector to introduce and encourage the usage of latest synthetic bone grafts and demineralized allografts. This report mainly considers four type
Post a Comment
Read more

Cartilage Regeneration Market | Growth and Analysis, Industry Trends, Size, Shares, Forecast

The global  cartilage regeneration market  is projected to reach USD 779.8 Million by 2021 from USD 414.6 Million in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. Increase in obese population and rising incidence of sports injuries are the major factors driving the growth of cartilage regeneration market. However, high cost of therapy and unfavorable reimbursement scenario are the major factors that are restraining the growth of the market. The cartilage regeneration market is segmented on the basis of treatment modalities, application, and region. Based on treatment modalities, the market is segmented into cell based approaches and non-cell based approaches. Cell based approaches are further segmented into chondrocyte transplantation, growth factor technology, and stem cells. Non-cell based approaches are segmented into tissue scaffolds and cell-free composites. The cell based approaches segment is expected to account for the largest market share i
Post a Comment
Read more

Dental Bone Graft Substitutes Market Size, Share, Growth Drivers, Industry Analysis

The global dental bone graft substitutes market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Increasing demand from customers for dental bone graft substitutes, growing inclination towards cosmetic dentistry, and rising industry standards are spurring the growth of the dental bone grafts substitutes market. However, unfavorable reimbursement scenarios in some countries is hampering the growth of the dental bone grafts substitutes market. The global dental bone graft substitutes market is segmented on the basis of type, application, and region. The geographic analysis covers North America, Europe, Asia-Pacific, and Rest of the World (RoW). RoW includes Latin America, the Middle East, and Africa. The European region is estimated to account for the largest share of the dental bone graft substitutes market in 2016. As implant dentistry originated in the European region, the penetration rate of dental bone graft substitutes is very high in
Post a Comment
Read more